Luciana Nichita
Carol Davila University of Medicine and Pharmacy
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Luciana Nichita.
Oncology Letters | 2016
Sabina Zurac; Monica Neagu; Carolina Constantin; Mirela Cioplea; Roxana Nedelcu; Alexandra Bastian; Cristiana Popp; Luciana Nichita; R. Andrei; Tiberiu Tebeica; Cristiana Tanase; Virginia Chitu; Constantin Caruntu; Mihaela Adriana Ghita; Catalin Popescu; Daniel Boda; Bogdan Mastalier; Nicoleta Maru; Claudiu Daha; Bogdan Andreescu; Ioan Marinescu; Adrian Rebosapca; Florica Staniceanu; Gabriela Negroiu; Daniela Adriana Ion; Dragana Nikitovic; Demetrios A. Spandidos; Aristidis M. Tsatsakis
Regression in melanoma is a frequent biological event of uncertain prognostic value as the lesion exhibits heterogeneous phenotypical features, both at the morphological and immunohistochemical level. In the present study, we examined the expression of tissue inhibitors of metalloproteinases (TIMP1, TIMP2 and TIMP3) in melanoma with regression. We specifically examined the expression levels of these TIMPs in regressed components (RC) and non-regressed components (NRC) of the tumor and compared their expression levels with those in non-regressed melanomas. We found that TIMP1 was overexpressed in the NRC of melanomas with partial regression (PR) compared with the NRC in melanomas with segmental regression (SR) (P=0.011). TIMP2 was overexpressed in the NRC of melanomas with PR compared with the NRC in melanomas with SR (PR/SR, P=0.009); or compared with the NRC in melanomas with simultaneous SR-PR (P=0.002); or compared with melanomas without regression (absence of regression) (P=0.037). Moreover, TIMP3 was overexpressed in the NRC of all melanomas with SR as compared to the RC component (P=0.007). Our findings on the differential expression of TIMP1, TIMP2 and TIMP3 in melanomas with regression support the hypothesis that the morphological differences identified in the melanoma regression spectrum may have a correlation with prognosis. This may explain the controversial findings within the literature concerning the biological and prognostic role of regression in melanoma.
Disease Markers | 2016
Cristiana Popp; Luciana Nichita; Theodor Voiosu; Alexandra Bastian; Mirela Cioplea; Gianina Micu; Gabriel Pop; Liana Sticlaru; Andreea Bengus; Andrei Voiosu; Radu Bogdan Mateescu
Ulcerative colitis (UC) is a chronic, relapsing inflammatory bowel disease that slightly increases the risk of colorectal cancer in patients with long-standing extended disease. Overexpression of p53 and p21 in colonic epithelia is usually detected in UC patients when no dysplasia is histologically seen and it is used by pathologists as a discriminator between regenerative changes and intraepithelial neoplasia, as well as a tissue biomarker useful to predict the risk of evolution toward malignancy. We present a one-year prospective observational study including a cohort of 45 patients with UC; p53 and p21 were evaluated in epithelial cells. p53 was positive in 74 samples revealed in 5% to 90% of epithelial cells, while 63 biopsies had strong positivity for p21 in 5% to 50% of epithelial cells. Architectural distortion was significantly correlated with p53 overexpression in epithelial cells. Thus, we consider that architectural distortion is a good substitute for p53 and p21 expression. We recommend use of p53 as the most valuable tissue biomarker in surveillance of UC patients, identifying the patients with higher risk for dysplasia. Association of p21 is also recommended for a better quantification of risk and for diminishing the false-negative results.
Journal of Immunoassay & Immunochemistry | 2018
Liana Sticlaru; Florica Stăniceanu; Mirela Cioplea; Luciana Nichita; Alexandra Bastian; Geanina Micu; Cristiana Popp
ABSTRACT It is suggested that different neuropeptides are actively involved in the pathogenesis of Helicobacter pylori (H. pylori)-induced gastritis acting as important effectors of the neuroimmune complex interactions, but the available data is limited and contradictory. The aim of this study was to determine whether the chronic infection generates changes in substance P (SP) and vasoactive intestinal peptide (VIP) gastric level and to evaluate the dependence of these potential effects on the degree of bacterial colonization or the severity of the inflammatory infiltrate. Therefore, immunohistochemical tests were performed to examine SP and VIP expression in mucosal nerve endings and myenteric neurons. Both SP and VIP levels were significantly higher in gastric samples of patients infected with H. pylori compared to uninfected individuals, confirming that these neuropeptides are neuroimmune modulators involved in the pathogenesis of H. pylori infection. Although their expression did not correlate with the intensity of mucosal inflammation nor with the bacterial density, we observed a strong association between SP neuronal level and the degree of myenteric ganglionitis, which in turn correlated with the severity of mucosal T-cell infiltration. These findings suggest that the mechanisms of neuroimmune cross-talk depend on some other factors that remain to be determined.
Clinical & Developmental Immunology | 2018
Vlad Marian Anghelescu; Ioana Neculae; Octavian Dincă; Cristian Vlădan; C. Socoliuc; Mirela Cioplea; Luciana Nichita; Cristiana Popp; Sabina Zurac; Alexandru Bucur
Introduction The clinical use of bioactive materials for bone augmentation has remained a challenge because of predictability and effectiveness concerns, as well as increased costs. The purpose of this study was to analyse the ability to integrate bone substitutes by evaluating the immunohistochemical expression of the platelet endothelial cell adhesion molecules, vascular endothelial growth factor, collagen IV, laminin, and osteonectin, in the vicinity of bone grafts, enabling tissue revascularization and appearance of bone lamellae. There is a lack of in vivo studies of inflammatory-driven angiogenesis in bone engineering using various grafts. Methods The study was performed in animal experimental model on the standardized monocortical defects in the tibia of 20 New Zealand rabbits. The defects were augmented with three types of bone substituents. The used bone substituents were beta-tricalcium phosphate, bovine hydroxyapatite, and bioactive glasses. After a period of 6 months, bone fragments were harvested for histopathologic examination. Endothelial cell analysis was done by analysing vascularization with PECAM/CD31 and VEGF and fibrosis with collagen IV, laminin, and osteonectin stains. Statistical analysis was realized by descriptive analysis which was completed with the kurtosis and skewness as well as the Kruskal-Wallis and Mann-Whitney statistical tests. Results The discoveries show that the amount of bone that is formed around beta-tricalcium phosphate and bovine hydroxyapatite is clearly superior to the bioactive glasses. Both the lumen diameter and the number of vessels were slightly increased in favor of beta-tricalcium phosphate. Conclusion We can conclude that bone substitutes as bovine bone and beta-tricalcium phosphate have significant increased angiogenesis (and subsequent improved osteogenesis) compared to the bioactive glass. In our study, significant angiogenesis is linked with a greater tissue formation, indicating that in bone engineering with the allografts we used, inflammation has more benefic effects, the catabolic action being exceeded by the tissue formation.
Romanian journal of internal medicine = Revue roumaine de médecine interne | 2009
Mihaela Girtan; Sabina Zurac; Florica Stăniceanu; Alexandra Bastian; Cristiana Popp; Luciana Nichita; Elisabeta Laba; Norina Forna
Romanian journal of internal medicine = Revue roumaine de médecine interne | 2011
Gianina Micu; Florica Stăniceanu; Sabina Zurac; Alexandra Bastian; Eliza Grămadă; Cristiana Popp; Luciana Nichita; R. Andrei; C. Socoliuc; Anca Zaharia; C. Lăzăroiu; Radu Bogdan Mateescu; Mădălina Marinescu; R. Voiosu
Romanian Journal of Clinical and Experimental Dermatology | 2017
Patricia-Irina Stinga; Alina Stoica; Mirela Cioplea; Sabina-Andrada Zurac; Luciana Nichita; Popp C; Alexandra Ioana Cioroianu; Alexandra Bastian
Archive | 2017
Alexandra Bastian; Luciana Nichita; Sabina Zurac
Archive | 2013
Luciana Nichita; Sabina Zurac; Cristiana Popp; Anca Streinu-Cercel
Romanian journal of internal medicine = Revue roumaine de medecine interne | 2011
Luciana Nichita; Sabina Zurac; Cristiana Popp; Gianina Micu; Alexandra Bastian; Florica Stăniceanu; Anca Streinu-Cercel